{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:00:05Z","timestamp":1787166005632,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jaad.2018.06.064","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T22:15:38Z","timestamp":1531174538000},"page":"120-127.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Methotrexate for alopecia areata: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"80","author":[{"given":"Kevin","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshan Frank","family":"Sebaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2018.06.064_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: a systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.06.064_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1067\/mjd.2000.103909","article-title":"Alopecia areata update","volume":"42","author":"Madani","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2018.06.064_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2133.2003.05535.x","article-title":"Guidelines for the management of alopecia areata","volume":"149","author":"MacDonald Hull","year":"2003","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2018.06.064_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0190-9622(99)70195-7","article-title":"Alopecia areata investigational assessment guidelines","volume":"40","author":"Olsen","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2018.06.064_bib5","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2018.06.064_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1381612013398266","article-title":"Current and potential agents for the treatment of alopecia areata","volume":"7","author":"Paul","year":"2001","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.jaad.2018.06.064_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000107626","article-title":"Pulse corticosteroid therapy for alopecia areata: study of 139 patients","volume":"215","author":"Nakajima","year":"2007","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2018.06.064_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000247268","article-title":"Pulse of methylprednisolone in alopecia areata","volume":"187","author":"Perriard-Wolfensberger","year":"1993","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2018.06.064_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","article-title":"Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients","volume":"39","author":"Friedli","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.06.064_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2230.2008.02976.x","article-title":"Methotrexate for psoriasis in the era of biological therapy","volume":"33","author":"Warren","year":"2008","journal-title":"Clinical and experimental dermatology"},{"key":"10.1016\/j.jaad.2018.06.064_bib11","first-page":"413","article-title":"Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema","volume":"10","author":"Zoller","year":"2008","journal-title":"The Israel Medical Association journal: IMAJ"},{"key":"10.1016\/j.jaad.2018.06.064_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2133.2009.09246.x","article-title":"Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid","volume":"161","author":"G\u00fcrcan","year":"2009","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1016\/j.jaad.2018.06.064_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/edm.09.45","article-title":"Treatment of pemphigus vulgaris and pemphigus foliaceus","volume":"4","author":"Sebaratnam","year":"2014","journal-title":"Expert Review of Dermatology"},{"key":"10.1016\/j.jaad.2018.06.064_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2005.09.010","article-title":"The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis","volume":"55","author":"Joly","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.jaad.2018.06.064_bib15","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The prisma statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.jaad.2018.06.064_bib16","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group","volume":"283","author":"Stroup","year":"2000","journal-title":"Jama"},{"key":"10.1016\/j.jaad.2018.06.064_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09546634.2017.1341608","article-title":"Methotrexate for the treatment of pediatric alopecia areata","volume":"29","author":"Landis","year":"2018","journal-title":"The Journal of dermatological treatment"},{"key":"10.1016\/j.jaad.2018.06.064_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5021\/ad.2017.29.3.263","article-title":"Low-dose systemic methotrexate therapy for recalcitrant alopecia areata","volume":"29","author":"Lim","year":"2017","journal-title":"Annals of dermatology"},{"key":"10.1016\/j.jaad.2018.06.064_bib19","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1111\/jdv.14291","article-title":"High-dose pulsed corticosteroid therapy combined with methotrexate for severe alopecia areata of childhood","volume":"31","author":"Chong","year":"2017","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"key":"10.1016\/j.jaad.2018.06.064_bib20","doi-asserted-by":"crossref","DOI":"10.12816\/0037811","article-title":"The effect of mehotrexate in the treatment of alopecia areata","volume":"67","author":"Alsufyani","year":"2017","journal-title":"Egyptian Journal of Hospital Medicine"},{"key":"10.1016\/j.jaad.2018.06.064_bib21","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1111\/1346-8138.14013","article-title":"Efficacy of combining pulse corticotherapy and methotrexate in alopecia areata: Real-life evaluation","volume":"44","author":"Alkeraye","year":"2017","journal-title":"The Journal of dermatology"},{"key":"10.1016\/j.jaad.2018.06.064_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2340\/00015555-2173","article-title":"Methotrexate in severe childhood alopecia areata: Long-term follow-up","volume":"96","author":"Lucas","year":"2016","journal-title":"Acta dermato-venereologica"},{"key":"10.1016\/j.jaad.2018.06.064_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/ijt.ijt_67_16","article-title":"Methotrexate in alopecia areata: A report of three cases","volume":"8","author":"Batalla","year":"2016","journal-title":"International journal of trichology"},{"key":"10.1016\/j.jaad.2018.06.064_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000441250","article-title":"Efficacy and safety of methotrexate combined with low- to moderate-dose corticosteroids for severe alopecia areata","volume":"232","author":"Anuset","year":"2016","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"10.1016\/j.jaad.2018.06.064_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4172\/2167-0951.1000138","article-title":"Methotrexate treatment for alopecia areata with greater than 50% involvement","volume":"5","author":"English","year":"2015","journal-title":"Hair Ther Transplant"},{"key":"10.1016\/j.jaad.2018.06.064_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1590\/abd1806-4841.20142869","article-title":"Efficacy and safety of methotrexate in alopecia areata","volume":"89","author":"Hammerschmidt","year":"2014","journal-title":"Anais brasileiros de dermatologia"},{"key":"10.1016\/j.jaad.2018.06.064_bib27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3923\/ajdd.2013.188.193","article-title":"Methotrexate plus prednisolone in severe alopecia areata","volume":"3","author":"Firooz","year":"2013","journal-title":"American Journal of Drug Discovery and Development"},{"key":"10.1016\/j.jaad.2018.06.064_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000339341","article-title":"Interest of high-dose pulse corticosteroid therapy combined with methotrexate for severe alopecia areata: A retrospective case series","volume":"224","author":"Droitcourt","year":"2012","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"10.1016\/j.jaad.2018.06.064_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2011.10383.x","article-title":"Efficacy and tolerability of methotrexate in severe childhood alopecia areata","volume":"165","author":"Royer","year":"2011","journal-title":"The British journal of dermatology"},{"key":"10.1016\/j.jaad.2018.06.064_bib30","unstructured":"Malekzad F, Eshghi GR, Ebadi A, Younespour SH. Treatment of severe alopecia areata using methotrexate as an adjunctive drug in combination with intravenous and oral corticosteroid. 2010."},{"key":"10.1016\/j.jaad.2018.06.064_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.annder.2010.06.031","article-title":"[long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis]","volume":"137","author":"Chartaux","year":"2010","journal-title":"Annales de dermatologie et de venereologie"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218322230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218322230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:49:04Z","timestamp":1759272544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218322230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0190962218322230"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.06.064","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate for alopecia areata: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.06.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}